MedTrace Logo

Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02708732 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2017-04-20

No results posted yet for this study

Summary

This study is a prospective, cross-sectional survey to be administered to real patients in remission from DLBCL using a 15-minute postal or online survey. The project is designed to describe the impact of DLBCL remission on health utility and quality of life. Data collection will occur over a 4-month period.

Conditions

  • Diffuse Large B-Cell Lymphoma

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02708732 on ClinicalTrials.gov